VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
-1.04%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$165M
AUM Growth
-$4.08M
(-2.4%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
6.09%
Holding
488
New
53
Increased
73
Reduced
307
Closed
54
Top Buys
| 1 |
Halliburton
HAL
|
$819K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$814K |
| 3 |
Steel Dynamics
STLD
|
$798K |
| 4 |
Caterpillar
CAT
|
$792K |
| 5 |
Booking.com
BKNG
|
$789K |
Top Sells
| 1 |
Netflix
NFLX
|
$1.05M |
| 2 |
Vulcan Materials
VMC
|
$1.01M |
| 3 |
CoStar Group
CSGP
|
$998K |
| 4 |
Eli Lilly
LLY
|
$967K |
| 5 |
Ingersoll Rand
IR
|
$913K |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Financials | 17.26% |
| 3 | Technology | 14.89% |
| 4 | Energy | 9.42% |
| 5 | Consumer Discretionary | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Crown Castle
CCI
$41.9B
| $167K | 0.1% |
1,811
+60
| +3% | +$5.52K |
|
|
GTY
302
Getty Realty Corp
GTY
$1.63B
| $166K | 0.1% |
5,995
-408
| -6% | -$11.3K |
|
303
B2Gold
BTG
$5.52B
| $165K | 0.1% |
57,063
-753
| -1% | -$2.18K |
|
304
Black Hills Corp
BKH
$4.35B
| $164K | 0.1% |
3,251
-421
| -11% | -$21.3K |
|
305
Eversource Energy
ES
$23.6B
| $163K | 0.1% |
2,807
-152
| -5% | -$8.84K |
|
306
Healthcare Realty
HR
$6.35B
| $163K | 0.1% |
10,642
-1,323
| -11% | -$20.2K |
|
307
Structure Therapeutics
GPCR
$1.27B
| $161K | 0.1% |
3,194
-319
| -9% | -$16.1K |
|
308
Travere Therapeutics
TVTX
$1.93B
| $161K | 0.1% |
17,981
-2,328
| -11% | -$20.8K |
|
309
PTC Therapeutics
PTCT
$4.55B
| $159K | 0.1% |
7,075
-914
| -11% | -$20.5K |
|
310
Lumen
LUMN
$4.87B
| $152K | 0.09% |
107,340
+19,559
| +22% | +$27.8K |
|
311
Gold Fields
GFI
$30.8B
| $151K | 0.09% |
13,926
-3,547
| -20% | -$38.5K |
|
|
DRD
312
DRDGold
DRD
$1.83B
| $151K | 0.09% |
18,168
-5,582
| -24% | -$46.3K |
|
313
Crinetics Pharmaceuticals
CRNX
$3.35B
| $144K | 0.09% |
4,849
-484
| -9% | -$14.4K |
|
314
Delek Logistics
DKL
$2.31B
| $144K | 0.09% |
3,435
-963
| -22% | -$40.4K |
|
315
Enanta Pharmaceuticals
ENTA
$189M
| $143K | 0.09% |
12,784
-1,654
| -11% | -$18.5K |
|
316
AngloGold Ashanti
AU
$30.2B
| $138K | 0.08% |
8,763
-1,213
| -12% | -$19.2K |
|
317
Braskem
BAK
$1.41B
| $136K | 0.08% |
16,562
-17,909
| -52% | -$147K |
|
318
Lexicon Pharmaceuticals
LXRX
$396M
| $133K | 0.08% |
121,711
-15,739
| -11% | -$17.2K |
|
319
Apellis Pharmaceuticals
APLS
$3.55B
| $126K | 0.08% |
3,301
-429
| -12% | -$16.3K |
|
320
Medical Properties Trust
MPW
$2.77B
| $123K | 0.07% |
22,566
-7,257
| -24% | -$39.6K |
|
|
EQRX
321
DELISTED
EQRx, Inc. Common Stock
EQRX
| $121K | 0.07% |
54,639
-5,437
| -9% | -$12.1K |
|
|
MRTX
322
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $117K | 0.07% |
2,684
-268
| -9% | -$11.7K |
|
323
Dynavax Technologies
DVAX
$1.18B
| $116K | 0.07% |
7,831
-785
| -9% | -$11.6K |
|
324
Precigen
PGEN
$1.3B
| $113K | 0.07% |
79,754
-7,938
| -9% | -$11.3K |
|
|
TSVT
325
DELISTED
2seventy bio
TSVT
| $111K | 0.07% |
28,308
-3,657
| -11% | -$14.3K |
|